Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international panel of experts led by NDORMS researchers has developed a reporting guideline which supports the reporting quality of patent landscapes, ultimately promoting better informed decision-making in technology development and research direction.

Hands type on a laptop keyboard. Overlaid over the image is an icon of a lightbulb in white.

Patent landscapes are overviews of the patenting activity in a particular field of technology, locally or globally, and provide unique and valuable insights to government, industry or research leaders.

They help key stakeholders identify new areas for research and development and are used to inform policy discussions, strategic research planning and technology transfer.

With patent landscapes often forming the basis of future research agendas in any given field, and informing next steps in technological investment, it is critical we deliver excellent quality patent landscape articles and reports.

The reporting checklist “Reporting Items for Patent Landscapes” (RIPL), published in Nature Biotechnology, offers a framework for articles published in academic journals through a consensus-based set of minimum criteria to include in patent landscape articles. Not only does RIPL provide straightforward and robust support for authors and editors, but its take-up also aids reproducibility and evidence synthesis.

“We want to improve the reporting of patent landscapes to ensure their societal impact is as significant as it can be. The reporting guidelines we have developed aim to do just that by providing support for authors, reviewers and editors working on patent landscape articles.” says Professor Andrew Carr.

Many patent landscapes are now gaining widespread attention through publication in high-impact journals, but unfortunately recent research showed their reporting to be inadequate.

Professor Carr adds: “In addition to authors and editors using RIPL, journal endorsement of the guidelines would encourage adherence and provide a uniform set of requirements for authors publishing in the field. We hope journals are watching this space.”

Reporting guidelines are commonly used in publications of health and biomedical research, where they have shown to improve reporting quality and ultimately lead to better, more transparent research with greater potential for impact.

The guideline has been registered with the EQUATOR Network, an international initiative that seeks to improve the reliability and value of published health research literature by promoting transparent and accurate reporting and wider use of robust reporting guidelines.

Read the full paper

The Reporting Items for Patent Landscapes statement

Nature Biotechnology volume36pages10431047 (2018)

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.

Building a humanoid bioreactor

A humanoid robot is being used at NDORMS in an attempt to grow tendon tissue for repairing shoulder injuries.